NCT00912834

Brief Summary

To understand the urine analysis of athletes

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
300

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Dec 2008

Shorter than P25 for all trials

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2008

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2009

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

June 2, 2009

Completed
1 day until next milestone

First Posted

Study publicly available on registry

June 3, 2009

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2009

Completed
Last Updated

September 23, 2009

Status Verified

June 1, 2009

Enrollment Period

5 months

First QC Date

June 2, 2009

Last Update Submit

September 22, 2009

Conditions

Proteinuria

Keywords

hematuriaurinary tract infection

Study Arms (7)

1

tract and field athletes

2

swimming athletes

3

tennis athletes

4

football athletes

5

basketball athletes

6

Badminton athletes

7

control group

Eligibility Criteria

Age18 Years - 25 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

In some types exercise, including basketball, swimming, tract \& field, tennis, football athletes, we make a study analysis of their urine data to find any abnormality such as microhematuria, proteinuria or pyuria.

You may qualify if:

  • proteinuria, hematuria, pyuria

You may not qualify if:

  • bacteriuria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

ProteinuriaHematuriaUrinary Tract Infections

Condition Hierarchy (Ancestors)

Urination DisordersUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesUrological ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsHemorrhagePathologic ProcessesInfections

Study Officials

  • Chung Yin Wu, MD

    Chung Yin Wu

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER

Study Record Dates

First Submitted

June 2, 2009

First Posted

June 3, 2009

Study Start

December 1, 2008

Primary Completion

May 1, 2009

Study Completion

November 1, 2009

Last Updated

September 23, 2009

Record last verified: 2009-06